You are here

Neupogen

Novartis copy of Amgen biotech drug shows similar efficacy-study

Yahoo/Reuters

Mon, 12/8/14 - 08:24 am

Amgen and Sandoz Square Off Over a Biosimilar Application

WSJ Pharmalot

Mon, 11/3/14 - 11:45 am

Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft

FDA Law Blog

Thu, 10/30/14 - 05:43 pm

Novartis CEO Jimenez shrugs off biosimilars in the short term

Fierce Pharma

Tue, 08/26/14 - 12:35 pm

U.S. paves way for Novartis to copy Amgen biotech drug

Yahoo/Reuters

Thu, 07/24/14 - 09:07 am

Amgen: Grappling With The Reality Of Patent Expiries

Seeking Alpha

Fri, 07/18/14 - 09:59 am

3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months

Motley Fool

Fri, 11/1/13 - 08:38 am

Generic Threats To Amgen's Biologics

Seeking Alpha

Thu, 06/6/13 - 11:49 am

[video]3 Amgen Biologics Facing Generic Competition

Motley Fool

Fri, 05/31/13 - 09:28 am

FDA delays ruling on Teva version of Amgen drug

Yahoo/AP

Fri, 10/1/10 - 12:16 pm

Teva Pharmaceuticals

No Drug Can Cure the Health-Care Reform Infection

Motley Fool

Thu, 04/22/10 - 08:12 pm

healthcare reform

Abbott Laboratories

Who wins, who loses with biogenerics

Marketwatch

Wed, 09/2/09 - 09:43 am

Three Rivers Pharmaceuticals

Sandoz Gets EU Nod for Version of Amgen’s Neupogen

Bloomberg

Fri, 02/13/09 - 07:20 am

Pages